SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-001631
Filing Date
2023-02-21
Accepted
2023-02-21 16:00:26
Documents
12
Period of Report
2023-02-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20230221x8k.htm   iXBRL 8-K 39292
  Complete submission text file 0001558370-23-001631.txt   157403

Data Files

Seq Description Document Type Size
2 EX-101.SCH glyc-20230221.xsd EX-101.SCH 3375
3 EX-101.LAB glyc-20230221_lab.xml EX-101.LAB 15361
4 EX-101.PRE glyc-20230221_pre.xml EX-101.PRE 10380
6 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20230221x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 23647963
SIC: 2834 Pharmaceutical Preparations